Found: 13
Select item for more details and to access through your institution.
Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0124643
- By:
- Publication type:
- Article
Inhibition of p110δ PI3K prevents inflammatory response and restenosis after artery injury.
- Published in:
- Bioscience Reports, 2017, v. 37, n. 5, p. 1, doi. 10.1042/BSR20171112
- By:
- Publication type:
- Article
Effects of biventricular pacing on interstitial remodelling, tumor necrosis factor-α expression, and apoptotic death in failing human myocardium.
- Published in:
- European Heart Journal, 2006, v. 27, n. 2, p. 201, doi. 10.1093/eurheartj/ehi579
- By:
- Publication type:
- Article
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway.
- Published in:
- Cardiovascular Research, 2012, v. 96, n. 3, p. 381, doi. 10.1093/cvr/cvs261
- By:
- Publication type:
- Article
Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression
- Published in:
- Cardiovascular Research, 2007, v. 76, n. 3, p. 453, doi. 10.1016/j.cardiores.2007.07.012
- By:
- Publication type:
- Article
Aldosterone receptor blockade improves left ventricular remodeling and increases ventricular fibrillation threshold in experimental heart failure
- Published in:
- Cardiovascular Research, 2003, v. 58, n. 3, p. 555, doi. 10.1016/S0008-6363(03)00251-7
- By:
- Publication type:
- Article
Ranolazine protects from doxorubicin-induced oxidative stress and cardiac dysfunction.
- Published in:
- European Journal of Heart Failure, 2014, v. 16, n. 4, p. 358, doi. 10.1002/ejhf.50
- By:
- Publication type:
- Article
Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.
- Published in:
- European Journal of Heart Failure, 2011, v. 13, n. 12, p. 1264, doi. 10.1093/eurjhf/hfr143
- By:
- Publication type:
- Article
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01346-y
- By:
- Publication type:
- Article
Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2021, v. 8, n. 2, p. 1681, doi. 10.1002/ehf2.13067
- By:
- Publication type:
- Article
Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure.
- Published in:
- ESC Heart Failure, 2020, v. 7, n. 4, p. 1571, doi. 10.1002/ehf2.12706
- By:
- Publication type:
- Article
Antineoplastic-related cardiotoxicity, morphofunctional aspects in a murine model: contribution of the new tool 2D-speckle tracking.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6785, doi. 10.2147/OTT.S106528
- By:
- Publication type:
- Article
Metformin Prevents the Development of Chronic Heart Failure in the SHHF Rat Model.
- Published in:
- Diabetes, 2012, v. 61, n. 4, p. 944, doi. 10.2337/db11-1132
- By:
- Publication type:
- Article